Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 25 of 562 for:    Recruiting, Not yet recruiting, Available Studies | Teaching

Neurology Inpatient Clinical Education Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03826056
Recruitment Status : Recruiting
First Posted : February 1, 2019
Last Update Posted : May 3, 2019
Sponsor:
Information provided by (Responsible Party):
Vijay Renga, Dartmouth-Hitchcock Medical Center

Brief Summary:

The objective of this study is to compare the effectiveness of a personalized patient education program to the current hospital education and evaluate its impact using patient satisfaction scores.

The investigators hypothesize that a personalized patient education intervention will increase patient's understanding of their diagnosis and satisfaction with the care as reflected in the survey results.


Condition or disease Intervention/treatment Phase
Myasthenia Gravis Guillain-Barre Syndrome Multiple Sclerosis Seizures Parkinsonism Meningitis Encephalitis Headache Vestibular Disorder Spondylosis Normal Pressure Hydrocephalus Behavioral: Current standard discharge educational intervention Behavioral: Personalized discharge educational intervention Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:

Study team members will randomize patients to receive either the current standard hospital education material or the new personalized education material. Investigators will use a stratified randomization process to allocate the patients from different categories including age range, gender, and discharge diagnosis into each group. Thereby the investigators will achieve equal distribution of diagnoses and other demographics among groups in real time. They will review the two groups when performing statistical analysis near the end of the study to ensure heterogeneity of distribution.

A study team member who has also been a member of the care team will use the either the current hospital standard or the new personalized education materials to explain the discharge diagnosis to the patient, the treatment, and the follow up needed. The study team member will also give a survey with a preaddressed envelope to each participant to complete at his or her convenience.

Masking: Single (Participant)
Masking Description: The patient will not be informed of whether he or she is receiving the current hospital standard or the new personalized patient education intervention. The study team member will known which intervention is being used for patient education. The intervention arm will not be blinded in the data analysis.
Primary Purpose: Health Services Research
Official Title: Neurology Inpatient Clinical Education Trial
Actual Study Start Date : February 1, 2019
Estimated Primary Completion Date : October 31, 2019
Estimated Study Completion Date : December 27, 2019


Arm Intervention/treatment
Active Comparator: Current standard education group
A study team member will use the current hospital standard educational material to explain the discharge diagnosis to the patient, the treatment, and the follow up needed. The study team member will also give a survey with a preaddressed envelope to each participant to complete at his or her convenience.
Behavioral: Current standard discharge educational intervention
The patients will receive the current hospital standard discharge educational material which explains the diagnosis, new medications, follow up and any activity/diet restrictions. A member of the study team will explain this material to the patient and answer any questions.

Experimental: New personalized education group
A study team member will use the new personalized educational materials to explain the discharge diagnosis to the patient, the treatment, and the follow up needed. The study team member will also give a survey with a preaddressed envelope to each participant to complete at his or her convenience.
Behavioral: Personalized discharge educational intervention
The patients will receive a new personalized discharge educational material which will explain the specifics of their disorder, the treatment, and prognosis. The materials will contain simple, organized explanations and graphics. A member of the study team will explain this material to the patient and answer any questions.




Primary Outcome Measures :
  1. Patient satisfaction scores [ Time Frame: Subjects will be expected to mail the feedback forms within 2 weeks of discharge. Investigators will mail a single reminder prepaid return mail with a copy of the questionnaire to patients who do not respond within this time allowing 1 month total time. ]
    The patients will answer a survey consisting of seven multiple-choice questions regarding their perception of the education intervention. Each questions will be scored on a scale of one to four for a total possible score of 28 for all 7 questions. A score of 1 indicates a negative perception of the education whereas 4 indicates the most positive impression. Therefore the lowest possible score is 7 for a severely negative perception of the education and the highest score is 28 for a very positive impression of the education program. Only the total scores will be compared for statistical analysis. Scores from patients in the current standard and new personalized education intervention groups will be compared.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 95 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Over the age of 18
  • Must have the capacity to consent and understand the study related activities and education materials.

Exclusion Criteria:

  • Under the age of 18
  • Have a condition that impairs the ability to understand the study, its risks, and appropriately consent for the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03826056


Contacts
Layout table for location contacts
Contact: Devin E Prior, MD 6036505104 devin.e.prior@hitchcock.org
Contact: Kyrillos Eskander, MD 6036505104 kyrillos.r.eskander@hithcock.org

Locations
Layout table for location information
United States, New Hampshire
Dartmouth- Hitchcock Medical Center Recruiting
Lebanon, New Hampshire, United States, 03756
Contact: Vijay Renga, MD    603-650-5104    vijay.renga@hitchcock.org   
Contact: Devin E Prior, MD    6036505104    devin.e.prior@hitchcock.org   
Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Vijay Renga, MD Dartmouth-Hitchcock Medical Center

Layout table for additonal information
Responsible Party: Vijay Renga, Principal Investigator, Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier: NCT03826056     History of Changes
Other Study ID Numbers: D19046
First Posted: February 1, 2019    Key Record Dates
Last Update Posted: May 3, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Investigators will protect patients' identity by using identification numbers that do not correspond to any personal identification information. They will enter the survey results to the institution's safely encrypted database.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Vijay Renga, Dartmouth-Hitchcock Medical Center:
clinical education
Additional relevant MeSH terms:
Layout table for MeSH terms
Spondylosis
Vestibular Diseases
Multiple Sclerosis
Seizures
Meningitis
Encephalitis
Hydrocephalus
Myasthenia Gravis
Parkinsonian Disorders
Hydrocephalus, Normal Pressure
Guillain-Barre Syndrome
Headache
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases
Pain
Neurologic Manifestations
Signs and Symptoms
Central Nervous System Diseases
Brain Diseases
Neuromuscular Junction Diseases
Neuromuscular Diseases
Basal Ganglia Diseases
Movement Disorders
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases